PMID- 24634792 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20140317 LR - 20211021 IS - 2090-9446 (Print) IS - 2090-9446 (Electronic) IS - 2090-9446 (Linking) VI - 2013 DP - 2013 TI - Adipokines, oxidized low-density lipoprotein, and C-reactive protein levels in lean, overweight, and obese portuguese patients with type 2 diabetes. PG - 142097 LID - 10.1155/2013/142097 [doi] LID - 142097 AB - Aim. Our aim was to study how different BMI scores may influence the levels of inflammation, oxidative stress, adipogenesis, glucose, and lipid metabolism, in lean, overweight, and obese Portuguese patients with type 2 diabetes mellitus (T2DM). Methods. We studied 28 lean, 38 overweight, and 17 obese patients with T2DM and 20 controls (gender and age matched). The circulating levels of oxLDL, CRP, and some adipokines-adiponectin, leptin, and chemerin-and the lipid profile were evaluated. Results. Obese patients presented significantly lower levels of adiponectin and higher leptin, oxLDL, and chemerin levels, as compared to the overweight, lean, and control groups. Overweight, compared to lean and control, subjects showed significantly lower adiponectin and higher leptin and chemerin levels; oxLDL values were significantly higher in overweight than in lean patients. Lean patients presented significantly higher chemerin values than the control. Obese patients presented significantly higher CRP values, as compared to lean patients and the control group. Obese and overweight patients presented significantly higher triglycerides values than lean patients. Except for CRP, all the observed significant changes between control and patients remained significant after statistical adjustment for the body mass index (BMI). Conclusion. The levels of leptin, adiponectin, oxLDL, CRP, and triglycerides in patients with T2DM seem to be more associated with obesity and less with diabetes. Chemerin levels were raised in lean, overweight, and obese patients, suggesting that, independently of BMI, an adipocyte dysfunction occurs. Moreover, chemerin may provide an important early biomarker of adipocyte dysfunction and a link between obesity and type 2 diabetes mellitus. FAU - Neuparth, Maria Joao AU - Neuparth MJ AD - Centro de Investigacao em Actividade Fisica, Saude e Lazer, Universidade do Porto, Rua Dr. Placido Costa 91, 4200-450 Porto, Portugal ; Centro de Investigacao das Tecnologias da Saude (CITS), Instituto Politecnico da Saude do Norte (IPSN), Cooperativa de Ensino Superior, Politecnico e Universitario (CESPU), Rua Jose Antonio Vidal 81, 4760-409 Vila Nova de Famalicao, Portugal. FAU - Proenca, Jorge Brandao AU - Proenca JB AD - Instituto Superior de Ciencias da Saude Norte (ISCS-N), CESPU, Rua Central de Gandra 1317, 4585-116 Gandra, Portugal. FAU - Santos-Silva, Alice AU - Santos-Silva A AD - Laboratorio de Bioquimica, Departamento de Ciencias Biologicas, Faculdade de Farmacia, Universidade do Porto, Rua de Jorge Viterbo 228, 4050-313 Porto, Portugal ; Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. FAU - Coimbra, Susana AU - Coimbra S AD - Centro de Investigacao das Tecnologias da Saude (CITS), Instituto Politecnico da Saude do Norte (IPSN), Cooperativa de Ensino Superior, Politecnico e Universitario (CESPU), Rua Jose Antonio Vidal 81, 4760-409 Vila Nova de Famalicao, Portugal ; Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. LA - eng PT - Journal Article DEP - 20130117 PL - United States TA - ISRN Obes JT - ISRN obesity JID - 101607056 PMC - PMC3901968 EDAT- 2013/01/01 00:00 MHDA- 2013/01/01 00:01 PMCR- 2013/01/17 CRDT- 2014/03/18 06:00 PHST- 2012/10/19 00:00 [received] PHST- 2012/11/26 00:00 [accepted] PHST- 2014/03/18 06:00 [entrez] PHST- 2013/01/01 00:00 [pubmed] PHST- 2013/01/01 00:01 [medline] PHST- 2013/01/17 00:00 [pmc-release] AID - 10.1155/2013/142097 [doi] PST - epublish SO - ISRN Obes. 2013 Jan 17;2013:142097. doi: 10.1155/2013/142097. eCollection 2013.